Gammagard and Tachypnea - a phase IV clinical study of FDA data

Summary:

Tachypnea is reported as a side effect among people who take Gammagard (immune globulin), especially for people who are male, 2-9 old, have been taking the drug for < 1 month also take Aspirin, and have Kawasaki's disease.

The phase IV clinical study analyzes which people have Tachypnea when taking Gammagard. It is created by eHealthMe based on reports of 8,933 people who have side effects when taking Gammagard from the FDA, and is updated regularly.

What is Gammagard?

Gammagard has active ingredients of immune globulin. eHealthMe is studying from 8,948 Gammagard users. Check the latest studies of Gammagard.

What is Tachypnea?

Tachypnea is found to be associated with 1,068 drugs and 1,939 conditions by eHealthMe. Check the latest studies of Tachypnea.

On Jul, 15, 2026

8,933 people reported to have side effects when taking Gammagard.
Among them, 39 people (0.44%) have Tachypnea.

Among these 39 people:

How long have people been on Gammagard when they have Tachypnea? *

What is the gender of people who have Tachypnea when taking Gammagard? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Tachypnea when taking Gammagard? *

What are other drugs people take besides Gammagard? *

What are other side effects people have besides Tachypnea? *

Chills (felling of cold): 21 people, 53.85%
Dyspnea (difficult or laboured breathing): 20 people, 51.28%
Arrhythmias (irregular heartbeat): 19 people, 48.72%
Fever: 19 people, 48.72%
Nausea And Vomiting: 14 people, 35.90%
Body Temperature Increased: 12 people, 30.77%
Pain In Extremity: 11 people, 28.21%
Tremor (trembling or shaking movements in one or more parts of your body): 10 people, 25.64%
Infusion Related Reaction: 9 people, 23.08%
High Blood Pressure: 9 people, 23.08%

What are the existing conditions these people have? *

Kawasaki's Disease (an autoimmune disease in which the medium-sized blood vessels throughout the body become inflamed): 12 people, 30.77%
Pulmonary Embolism (blockage of the main artery of the lung): 6 people, 15.38%
Stiff Person Syndrome: 5 people, 12.82%
Encephalopathy (functioning of the brain is affected by some agent or condition): 5 people, 12.82%
Optic Neuritis (optic nerve inflammation): 4 people, 10.26%
Secondary Immunodeficiency (lack of immunity due to some disease): 3 people, 7.69%
Immunodeficiency Common Variable: 2 people, 5.13%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 2.56%
B-Cell Type Acute Leukaemia (cancer of the white blood cells): 1 person, 2.56%
Fever: 1 person, 2.56%

* Approximation only. Some reports may have incomplete information.

Do you take Gammagard and have Tachypnea?

- Check whether Tachypnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gammagard:

Gammagard (8,948 reports)

Tachypnea treatments and more:

Tachypnea (16,675 reports)

Browse all side effects of Gammagard:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tachypnea:

Tachypnea (1,068 drugs)

Browse all the conditions that are associated with Tachypnea:

Tachypnea (1,939 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on immune globulin (the active ingredients of Gammagard) and Gammagard (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.